Brind.

Angle and Myriad Genetics are collaborating, with Angle providing CTCs from tissue tests for Myriad's molecular analysis, aiming to extend to blood samples.

1 report, 1 independent Updated Aug 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Angle and Myriad Genetics are collaborating, with Angle providing CTCs from tissue tests for Myriad's molecular analysis, aiming to extend to blood samples.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ACCESS NewswireANGLE Announces Collaboration with Myriad Genetics Assessment of feasibility for use of Parsortix derived circulating tumour cell (CTC) DNA with Myriad Genetics' existing tissue-based diagnostic test